搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Bacillus subtilis SPBc2 prophage-derived uncharacterized protein yonT (yonT), partial CSB-YP520058BRJ
CSB-EP520058BRJ
CSB-BP520058BRJ
CSB-MP520058BRJ
CSB-EP520058BRJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus subtilis SPBc2 prophage-derived uncharacterized protein yonJ (yonJ) CSB-YP520059BRJ
CSB-EP520059BRJ
CSB-BP520059BRJ
CSB-MP520059BRJ
CSB-EP520059BRJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus subtilis SPBc2 prophage-derived uncharacterized protein yonE (yonE), partial CSB-YP520060BRJ
CSB-EP520060BRJ
CSB-BP520060BRJ
CSB-MP520060BRJ
CSB-EP520060BRJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus subtilis SPBc2 prophage-derived uncharacterized protein yonA (yonA) CSB-YP520061BRJ
CSB-EP520061BRJ
CSB-BP520061BRJ
CSB-MP520061BRJ
CSB-EP520061BRJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus subtilis SPBc2 prophage-derived uncharacterized protein yomU (yomU) CSB-YP520062BRJ
CSB-EP520062BRJ
CSB-BP520062BRJ
CSB-MP520062BRJ
CSB-EP520062BRJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus subtilis SPBc2 prophage-derived uncharacterized protein yomQ (yomQ) CSB-YP520063BRJ
CSB-EP520063BRJ
CSB-BP520063BRJ
CSB-MP520063BRJ
CSB-EP520063BRJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus subtilis SPBc2 prophage-derived uncharacterized membrane protein yomJ (yomJ), partial CSB-YP520064BRJ1
CSB-EP520064BRJ1
CSB-BP520064BRJ1
CSB-MP520064BRJ1
CSB-EP520064BRJ1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus subtilis SPBc2 prophage-derived uncharacterized protein yomG (yomG), partial CSB-YP520065BRJ
CSB-EP520065BRJ
CSB-BP520065BRJ
CSB-MP520065BRJ
CSB-EP520065BRJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus subtilis SPBc2 prophage-derived protein BhlA (bhlA) CSB-YP520066BRJ
CSB-EP520066BRJ
CSB-BP520066BRJ
CSB-MP520066BRJ
CSB-EP520066BRJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus subtilis SPBc2 prophage-derived uncharacterized protein yolD (yolD) CSB-YP520067BRJ
CSB-EP520067BRJ
CSB-BP520067BRJ
CSB-MP520067BRJ
CSB-EP520067BRJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus subtilis SPBc2 prophage-derived uncharacterized protein yolB (yolB) CSB-YP520068BRJ
CSB-EP520068BRJ
CSB-BP520068BRJ
CSB-MP520068BRJ
CSB-EP520068BRJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus subtilis SPBc2 prophage-derived UPF0720 protein yokI (yokI), partial CSB-YP520069BRJ
CSB-EP520069BRJ
CSB-BP520069BRJ
CSB-MP520069BRJ
CSB-EP520069BRJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus subtilis SPBc2 prophage-derived aminoglycoside N (3')-acetyltransferase-like protein yokD CSB-YP520070BRJ
CSB-EP520070BRJ
CSB-BP520070BRJ
CSB-MP520070BRJ
CSB-EP520070BRJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus subtilis Uncharacterized protein ypzC (ypzC) CSB-YP520071BRJ
CSB-EP520071BRJ
CSB-BP520071BRJ
CSB-MP520071BRJ
CSB-EP520071BRJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus subtilis Uncharacterized protein yqzE (yqzE) CSB-YP520072BRJ
CSB-EP520072BRJ
CSB-BP520072BRJ
CSB-MP520072BRJ
CSB-EP520072BRJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus subtilis Uncharacterized protein yrzI (yrzI) CSB-YP520073BRJ
CSB-EP520073BRJ
CSB-BP520073BRJ
CSB-MP520073BRJ
CSB-EP520073BRJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus subtilis Uncharacterized membrane protein yrrS (yrrS), partial CSB-YP520074BRJ1
CSB-EP520074BRJ1
CSB-BP520074BRJ1
CSB-MP520074BRJ1
CSB-EP520074BRJ1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus subtilis Putative O-methyltransferase yrrM (yrrM) CSB-YP520075BRJ
CSB-EP520075BRJ
CSB-BP520075BRJ
CSB-MP520075BRJ
CSB-EP520075BRJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus subtilis Putative N-acetylmuramoyl-L-alanine amidase YrvJ (yrvJ) CSB-YP520076BRJ
CSB-EP520076BRJ
CSB-BP520076BRJ
CSB-MP520076BRJ
CSB-EP520076BRJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus subtilis Protein translocase subunit SecDF (secDF), partial CSB-YP520077BRJ
CSB-EP520077BRJ
CSB-BP520077BRJ
CSB-MP520077BRJ
CSB-EP520077BRJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達載體的選擇、表達蛋白的長度(全長或部分)、是否帶標簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達載體?

表達載體是一種DNA分子,它攜帶特定的基因進入宿主細胞,并利用細胞的蛋白質(zhì)合成機制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達載體可使外源基因在宿主細胞中高效表達,經(jīng)過多年的發(fā)展,表達載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達載體。

第三條:如何表達具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達服務(wù),您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>